What Investors Are Expecting Ahead Of Multiple Nektar Therapeutics Catalysts
January 09, 2015 at 12:53 PM EST
Nektar Therapeutics (NASDAQ: NKTR) is a biotech company that develops drugs using PEGylation and polymer conjugates. The company has ...